In conclusion, these results suggest that the antiproliferative effect of β-elemene on glioblastoma is through the ERK1/2-Bcl-2/Survivin pathway, which is dependent on the inactivation of GMFβ. This evidence concerns the gene BCL2 and glioblastoma.